ArticleFrontiers in psychiatry2021

Early Clinical Effects of Novel Partial D3/D2 Agonist Cariprazine in Schizophrenia Patients With Predominantly Negative Symptoms (Open-Label, Non-controlled Study).

Stanislav V Ivanov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.